RHYTHM PHARMACEUTICALS, INC.
RYTM
43 insider filings · Latest: Sep 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Nov 6 10:07 PM | PAMELA CRAMER | Proposed Sale | 4,687 | $56.25 | $263.6K | — | View → |
| Sep 17, 2024 | Sep 17 8:42 PM | JENNIFER GOOD | Proposed Sale | 31,751 | $49.52 | $1.6M | — | View → |
| Sep 10, 2024 | Sep 10 8:22 PM | LYNN TETRAULT393 COMMONWEALTH AVE | Proposed Sale | 17,501 | $50.66 | $886.6K | — | View → |
| Sep 9, 2024 | Sep 9 8:31 PM | JENNIFER GOOD | Proposed Sale | 16,749 | $49.25 | $824.9K | — | View → |
| Aug 26, 2024 | Aug 26 8:27 PM | JENNIFER GOOD | Proposed Sale | 35,000 | $46.12 | $1.6M | — | View → |
| Aug 26, 2024 | Aug 26 8:27 PM | LYNN TETRAULT393 COMMONWEALTH AVE | Proposed Sale | 7,499 | $46.12 | $345.9K | — | View → |
| Aug 26, 2024 | Aug 26 8:26 PM | PAMELA CRAMER | Proposed Sale | 7,299 | $46.12 | $336.6K | — | View → |
| Nov 11, 2024 | — | JENNIFER KAYDEN LEE | Proposed Sale | 66,861 | $67.33 | $4.5M | — | View → |
| Nov 11, 2024 | — | JOSEPH J SHULMAN | Proposed Sale | 13,281 | $67.33 | $894.2K | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 3 9:36 PM | Yann MazabraudEVP, Head of International | Option Exercise | 12,875 | — | 5,000(D) | View → |
| Apr 1, 2026 | Apr 3 9:35 PM | Kimberly J PopovitsDirector | Grant/Award | 17,065 | $88.12 | 10,257(D) | View → |
| Mar 4, 2026 | Mar 6 9:51 PM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 1,500 | $17.97 | 3,731(D) | View → |
| Mar 2, 2026 | Mar 5 1:22 AM | Yann MazabraudEVP, Head of International | Grant/Award | 35,000 | $94.94 | 35,000(D) | View → |
| Mar 1, 2026 | Mar 4 12:45 AM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 1,162 | — | 1,162(D) | View → |
| Mar 2, 2026 | Mar 3 1:56 AM | Hunter C SmithChief Financial Officer | Option Exercise | 6,099 | $6.80 | 91,401(D) | View → |
| Feb 14, 2026 | Feb 18 9:30 PM | Yann MazabraudEVP, Head of International | Option Exercise | 10,000 | — | 30,000(D) | View → |
| Feb 11, 2026 | Feb 13 10:53 PM | Joseph ShulmanChief Technical Officer | Grant/Award | 37,500 | $98.47 | 22,500(D) | View → |
| Feb 11, 2026 | Feb 13 10:52 PM | David P MeekerDirector, President and CEO | Grant/Award | 179,750 | $98.47 | 107,850(D) | View → |
| Feb 11, 2026 | Feb 13 10:50 PM | Yann MazabraudEVP, Head of International | Grant/Award | 23,350 | — | 23,350(D) | View → |
| Feb 11, 2026 | Feb 13 10:49 PM | Jennifer Kayden LeeEVP, Head of North America | Grant/Award | 54,150 | $98.47 | 32,500(D) | View → |
| Feb 11, 2026 | Feb 13 10:48 PM | Christopher Paul GermanCorporate Controller & CAO | Grant/Award | 5,215 | — | 5,215(D) | View → |
| Feb 11, 2026 | Feb 13 10:47 PM | Alastair GarfieldChief Scientific Officer | Grant/Award | 41,650 | $98.47 | 25,000(D) | View → |
| Feb 11, 2026 | Feb 13 10:45 PM | Pamela J. CramerChief Human Resources Officer | Grant/Award | 29,150 | $98.47 | 17,500(D) | View → |
| Feb 11, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Grant/Award | 62,500 | $98.47 | 37,500(D) | View → |
| Feb 1, 2026 | Feb 3 9:38 PM | Yann MazabraudEVP, Head of International | Option Exercise | 5,500 | — | 11,000(D) | View → |
| Feb 1, 2026 | Feb 3 9:36 PM | Hunter C SmithChief Financial Officer | Option Exercise | 26,000 | — | 31,237(D) | View → |
| Feb 1, 2026 | Feb 3 9:35 PM | Joseph ShulmanChief Technical Officer | Option Exercise | 16,968 | — | 18,750(D) | View → |
| Feb 1, 2026 | Feb 3 9:34 PM | David P MeekerDirector, President and CEO | Option Exercise | 68,713 | — | 100,012(D) | View → |
| Feb 1, 2026 | Feb 3 9:33 PM | Jennifer Kayden LeeEVP, Head of North America | Option Exercise | 22,612 | — | 27,487(D) | View → |